Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in Depressed Patients with Mild Cognitive Impairment
NCT01658228Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Sep 2011
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of donepezil in Mild Cognitive Impairment (MCI), major depressive disorder (MDD), sponsored by New York State Psychiatric Institute. Started Sep 2011; status: completed.
02
Drugs
donepezil
03
Conditions
Mild Cognitive Impairment (MCI)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01658228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01658228.